课题基金 / 基金详情

Role of the CNS in the Metabolic Syndrome

Role of the CNS in the Metabolic Syndrome
中枢神经系统在代谢综合征中的作用
批准号:
7156709
负责人:
John Michael Stafford
金额:
$5.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-01-01 至 2009-06-30

项目摘要

项目成果

John Michael Stafford的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The prevalence of overweight children in the US has increased by more than 50% in the last 10 years. Body weight is tightly regulated through a negative endocrine feedback loop by communication of signals from adipose tissue to the CMS. The major health consequence of obesity is metabolic syndrome, defined as abdominal obesity, dyslipidemia, hypertension (HTN), and impaired glucose tolerance (IGT). Hypothalamic circuits are involved in the regulation of all of these traits. We hypothesize that CMS resistance to insulin and leptin leads; a) to increased food intake and obesity, and b) to traits of metabolic syndrome independent of the resultant obesity. The Zucker fatty rat (ZF) is a model of metabolic syndrome with obesity, HTN, dyslipidemia, and IGT. Our objective is to determine how insulin and leptin signaling in the hypothalamus regulates the traits of metabolic syndrome by determining when in post-partum development these traits occur. Next, using a gain-of-function approach we will determine if restoration of hypothalamic function can prevent the onset of a) adiposity and b) metabolic syndrome. Thus CNS resistance to insulin and leptin may be important in the development of obesity and metabolic syndrome in children and adolescents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COVID-19: HDL's Role in Innate Immunity and Cardiovascular Protection with COVID-19
  • 批准号:
    10153344
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2021
  • 负责人:
    John Michael Stafford
  • 依托单位:
COVID-19: HDL's Role in Innate Immunity and Cardiovascular Protection with COVID-19
  • 批准号:
    10404924
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2021
  • 负责人:
    John Michael Stafford
  • 依托单位:
CETP and Sex-Differences in Metabolic and Cardiovascular Disease
Therapeutic Potential of Estrogen-Regulated Metabolism and Cardiovascular Risk
海外基金